Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / SGTX - SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AMED KDNY SGTX


SGTX - SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AMED KDNY SGTX

NEW YORK, NY / ACCESSWIRE / July 20, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

Amedisys, Inc. (NASDAQ:AMED)'s sale to Optum for $101.00 per share.If you are an Amedisys shareholder, click here to learn more about your rights and options.

Chinook Therapeutics, Inc. (NASDAQ:KDNY)'s sale to Novartis AG for $40.00 per share in cash. Chinook shareholders will also receive contingent value rights providing for payment of up to $4.00 per share upon the achievement of certain future regulatory milestones with respect to Chinook's lead product candidate, atrasentan. If you are a Chinook shareholder, click here to learn more about your rights and options.

Sigilon Therapeutics, Inc. (NASDAQ:SGTX)'s sale to Eli Lilly and Company. Under the terms of the agreement, Eli Lilly would acquire all outstanding shares of Sigilon for $14.92 per share in cash payable at closing, plus one non-tradeable contingent value right per share that entitles the holder to receive up to an additional $111.64 per share in cash. If you are a Sigilon shareholder, click here to learn more about your rights and options.

Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Halper Sadeh LLC
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com
https://www.halpersadeh.com

SOURCE: Halper Sadeh LLC



View source version on accesswire.com:
https://www.accesswire.com/769349/SHAREHOLDER-INVESTIGATION-Halper-Sadeh-LLC-Investigates-AMED-KDNY-SGTX

Stock Information

Company Name: Sigilon Therapeutics Inc.
Stock Symbol: SGTX
Market: NASDAQ
Website: sigilon.com

Menu

SGTX SGTX Quote SGTX Short SGTX News SGTX Articles SGTX Message Board
Get SGTX Alerts

News, Short Squeeze, Breakout and More Instantly...